Population
MDA-MB-MD-231 cell lines and Sprague Dawley rats
Comparison
Oral ginsenoside Rg1 in DMBA-induced mammary gland carcinogenesis
Design
Preclinical in vitro and animal experimental study
Authors
Loading...
Hypothesis-generating for ginsenoside Rg1 in triple-negative breast cancer; leaves open clinical translation.
Ginsenoside Rg1 demonstrates significant anticancer properties against triple-negative breast cancer in both in vitro and in vivo experimental models.
Chu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: